臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或输入年份:

从最近的开始

由旧到新排序

显示项目 2233481-2233505 / 2346973 (共93879页)
<< < 89335 89336 89337 89338 89339 89340 89341 89342 89343 89344 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-08-31T05:35:47Z	The impact of appointment-based CEO connectedness on firms’ performance and profitability	Chien Y.-H;Hung M.-W.; Chien Y.-H; Hung M.-W.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Implications of default information leakage on recoveries	Hung M.-W;Tsai W.-H.; Hung M.-W; Tsai W.-H.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Consumption-based asset pricing with prospect theory and habit formation	Wang J.-Y;Hung M.-W.; Wang J.-Y; Hung M.-W.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Application of intertemporal CAPM on international corporate finance	Chang J.-R;Hung M.-W;Lee C.F.; Chang J.-R; Hung M.-W; Lee C.F.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:48Z	Forward osmosis membrane processes for wastewater bioremediation: Research needs	Lee D.-J;Hsieh M.-H.; Lee D.-J; Hsieh M.-H.; MING-HUEI HSIEH
臺大學術典藏	2021-08-31T05:35:48Z	Risk analysis of reservoir sedimentation under non-stationary flows	Tsai C.W;Yeh T.-G;Hsu Y;Wu K.-T;Liu W.-J.; Tsai C.W; Yeh T.-G; Hsu Y; Wu K.-T; Liu W.-J.; YAO-WEN HSU
臺大學術典藏	2021-08-31T05:35:48Z	A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan	Wu C.-C;Lin C.-H;Chiang H.-S;Tang M.-J.; Wu C.-C; Lin C.-H; Chiang H.-S; Tang M.-J.; MING JE TANG
臺大學術典藏	2021-08-31T05:44:40Z	Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium–intracellulare complex subspecies and antimicrobial susceptibility	Chang C.-L.; LUN-CHE CHEN; Yu C.-J.; Hsueh P.-R.; Chien J.-Y.
臺大學術典藏	2021-08-31T05:44:40Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.; Huang H.-L.; LUN-CHE CHEN; Yang H.-C.; Ko J.-C.; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-08-31T05:44:41Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	LUN-CHE CHEN; Shih J.-Y.; Yu C.-J.; Yang C.-Y.
臺大學術典藏	2021-08-31T05:44:41Z	Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates	LUN-CHE CHEN; Huang H.-N.; Yu C.-J.; Chien J.-Y.; Hsueh P.-R.
臺大學術典藏	2021-08-31T06:06:17Z	Impacts of treatments on recurrence and 28-year survival of ischemic stroke patients	Wang, Ting-Ann; TZY-HAW WU; Pan, Shin-Liang; Chen, Hsiu-Hsi; Chiu, Sherry Yueh-Hsia
臺大學術典藏	2021-08-31T06:29:13Z	Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression	Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S.
臺大學術典藏	2021-08-31T06:29:13Z	Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYnote-240	Ryoo B.-Y.; Merle P.; Kulkarni A.S.; ANN-LII CHENG; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Daniele B.; Norquist J.M.; Chen E.; Siegel A.B.; Zhu A.X.; Finn R.S.; Kudo M.
臺大學術典藏	2021-08-31T06:29:13Z	Pursuing efficacious systemic therapy for hepatocellular carcinoma	ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:13Z	An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma	Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:14Z	Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer	Kasper S.; Foch C.; Messinger D.; Esser R.; Lamy F.-X.; Rothe V.; Chen W.; ANN-LII CHENG; Rouyer M.; Brodowicz T.; Zielinski C.
臺大學術典藏	2021-08-31T06:29:14Z	Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma	Sangro B.; Melero I.; Wadhawan S.; Finn R.S.; Abou-Alfa G.K.; ANN-LII CHENG; Yau T.; Furuse J.; Park J.-W.; Boyd Z.; Tang H.T.; Shen Y.; Tschaika M.; Neely J.; El-Khoueiry A.
臺大學術典藏	2021-08-31T06:29:14Z	Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma	Kelley R.K.; Meyer T.; Rimassa L.; Merle P.; Park J.-W.; Yau T.; Chan S.L.; Blanc J.-F.; Tam V.C.; Tran A.; Dadduzio V.; Markby D.W.; Kaldate R.; ANN-LII CHENG; El-Khoueiry A.B.; Abou-Alfa G.K.
臺大學術典藏	2021-08-31T06:29:14Z	Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas	Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:15Z	A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women	Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; Huang C.-S.; ANN-LII CHENG; Lin C.-H.; Chen P.-C.
臺大學術典藏	2021-08-31T06:29:15Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG; Lee R.-C.; Chao Y.; Hsu C.
臺大學術典藏	2021-08-31T06:29:15Z	Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply	Finn R.S.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:16Z	Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial	Kelley R.K.; Ryoo B.-Y.; Merle P.; Park J.-W.; Bolondi L.; Chan S.L.; Lim H.Y.; Baron A.D.; Parnis F.; Knox J.; Cattan S.; Yau T.; Lougheed J.C.; Milwee S.; El-Khoueiry A.B.; ANN-LII CHENG; Meyer T.; Abou-Alfa G.K.
臺大學術典藏	2021-08-31T06:29:16Z	Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design	Kelley R.K.; W Oliver J.; Hazra S.; Benzaghou F.; Yau T.; ANN-LII CHENG; Rimassa L.

显示项目 2233481-2233505 / 2346973 (共93879页)
<< < 89335 89336 89337 89338 89339 89340 89341 89342 89343 89344 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :2854037
	造访人次 : 45304420 在线人数 : 1387 教育部委托研究计画计画执行:国立台湾大学图书馆